Regal Investment Advisors’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Regal Investment Advisors’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-700	Closed	-$12K	–	1090
2014 Q4	$12K	Hold	700	–	–	﹤0.01%	622
2014 Q3	$8K	Sell	700 -700	-50%	-$4.78K	﹤0.01%	739
2014 Q2	$8K	Hold	1,400	–	–	﹤0.01%	714
2014 Q1	$5K	Buy	+1,400	New	+$5.33K	﹤0.01%	757
2013 Q4	–	Sell	-1,400	Closed	-$6K	–	1019
2013 Q3	$6K	Hold	1,400	–	–	﹤0.01%	696
2013 Q2	$6K	Buy	+1,400	New	+$4.81K	﹤0.01%	685

Regal Investment Advisors's AVNR Position: Q1 2015 in Review

Regal Investment Advisors sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 700 shares — an estimated $12K sold.

Regal Investment Advisors first reported a position in AVNR in Q2 2013 and held it in 6 quarters. The position peaked at $12K in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Regal Investment Advisors reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Regal Investment Advisors sold 700 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $12K.
Regal Investment Advisors first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 6 quarters.
Regal Investment Advisors's AVANIR PHARMACEUTICALS, INC CL A position peaked at $12K in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Regal Investment Advisors's 13F filing for Q1 2015, filed 30 Apr 2015.